Efficacy and safety of 3-week response-guided triple direct-acting antiviral therapy for chronic hepatitis C infection: a phase 2, open-label, proof-of-concept study.

Efficacy and safety of 3-week response-guided triple direct-acting antiviral therapy for chronic hepatitis C infection: a phase 2, open-label, proof-of-concept study.

Item
http://www.wikidata.org/entity/Q38375284
Hepatitis C virus infection.Is the 25-year hepatitis C marathon coming to an end to declare victory?Shortening the duration of therapy for chronic hepatitis C infection.The paradox of highly effective sofosbuvir-based combination therapy despite slow viral decline: can we still rely on viral kinetics?No one size fits all-Shortening duration of therapy with direct-acting antivirals for hepatitis C genotype 1 infection.Sofosbuvir/velpatasvir: a pangenotypic drug to simplify HCV therapy.From HCV To HBV Cure.Modeling HCV cure after an ultra-short duration of therapy with direct acting agents.[Personalized treatment of viral hepatitis of the present and the future : Hepatitis B, C, delta, and E].Profile of Roche's cobas® HCV tests.Quantifying antiviral activity optimizes drug combinations against hepatitis C virus infection.Synthesis and anti-HCV activity of a series of β-d-2'-deoxy-2'-dibromo nucleosides and their corresponding phosphoramidate prodrugs.Predicting Early Viral Control under Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus Using Pretreatment Immunological Markers.Superinfection and cure of infected cells as mechanisms for hepatitis C virus adaptation and persistenceHA1077 displays synergistic activity with daclatasvir against hepatitis C virus and suppresses the emergence of NS5A resistance-associated substitutions in mice
P2860

Efficacy and safety of 3-week response-guided triple direct-acting antiviral therapy for chronic hepatitis C infection: a phase 2, open-label, proof-of-concept study.

Item
http://www.wikidata.org/entity/Q38375284
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Efficacy and safety of 3-week ...... label, proof-of-concept study.
@en
type
label
Efficacy and safety of 3-week ...... label, proof-of-concept study.
@en
prefLabel
Efficacy and safety of 3-week ...... label, proof-of-concept study.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Efficacy and safety of 3-week ...... label, proof-of-concept study.
@en
P2093
P2860
P304
P31
P356
10.1016/S2468-1253(16)30015-2
P433
P478
P50
P577
P698
P932